Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
751 GBX | +0.67% | +5.19% | -5.06% |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
Apr. 18 | DiscoverIE set to meet full-year expectations; maintains momentum | AN |
Sales 2024 * | 440M 549M | Sales 2025 * | 462M 576M | Capitalization | 714M 892M |
---|---|---|---|---|---|
Net income 2024 * | 20M 24.97M | Net income 2025 * | 21M 26.22M | EV / Sales 2024 * | 1.86 x |
Net Debt 2024 * | 105M 132M | Net Debt 2025 * | 89.79M 112M | EV / Sales 2025 * | 1.74 x |
P/E ratio 2024 * |
35.4
x | P/E ratio 2025 * |
32.1
x | Employees | 4,500 |
Yield 2024 * |
1.61% | Yield 2025 * |
1.7% | Free-Float | 95.94% |
Latest transcript on discoverIE Group plc
1 day | +0.67% | ||
1 week | +5.19% | ||
Current month | +6.38% | ||
1 month | -0.66% | ||
3 months | +3.59% | ||
6 months | +12.78% | ||
Current year | -5.06% |
Managers | Title | Age | Since |
---|---|---|---|
Nick Jefferies
CEO | Chief Executive Officer | 58 | 09-01-04 |
Simon Gibbins
DFI | Director of Finance/CFO | 58 | 10-07-19 |
Lili Huang
IRC | Investor Relations Contact | - | 21-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Clive Watson
BRD | Director/Board Member | 66 | 19-09-01 |
Bruce Thompson
CHM | Chairman | 69 | 18-02-25 |
Director/Board Member | 66 | 23-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 750 | +0.54% | 26 530 |
24-05-08 | 746 | +1.50% | 150,307 |
24-05-07 | 735 | +0.68% | 156,847 |
24-05-03 | 730 | +2.38% | 162,202 |
24-05-02 | 713 | -0.56% | 218,989 |
Delayed Quote London S.E., May 09, 2024 at 08:03 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.06% | 892M | |
+27.72% | 76.04B | |
+62.20% | 72.51B | |
-6.97% | 34.28B | |
-14.08% | 29.4B | |
-7.75% | 14.17B | |
-9.31% | 10.37B | |
+9.09% | 9.85B | |
-12.57% | 8.45B | |
+10.89% | 8.57B |
- Stock Market
- Equities
- DSCV Stock